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CAPSAICIN, substance P, and ovalbumin, instilled into the
bladders ofnaive and ovalbumin (OVA) sensitized guinea-
pigs caused inflammation, as indicated by increased vas-
cular permeability. Histological changes after exposure to
these compounds progressed with time from intense
vasodilatation to marginalization of granulocytes fol-
lowed by interstitial migration of leukocytes. In vitro
incubation of guinea-pig bladder tissue with substance P
and ovalbumin stimulated release of prostaglandin D
and leukotrienes. In vitro incubation of bladder tissue
with capsaicin, OVA, prostaglandin Da, leukotriene C4,
histamine, or calcium ionophore A-23587 all stimulated
substance P release. These data suggest that bladder in-
flammation initiated by a variety of stimuli could lead to
a cyclic pattern of release ofinflammatory mediators and
neuropeptides, which could result in amplification and
persistence of cystitis after the inciting cause has sub-
sided.
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Introduction
Apparently spontaneous inflammation of the uri-
nary bladder in the absence of infection has been
reported in humans and cats. 1,2 In humans, the most
widely recognized form of cystitis in the absence of
infection is interstitial cystitis (IC), a chronic inflam-
matory disease of the lower urinary tract. Clinical
symptoms commonly associated with IC include in-
creased urinary frequency and urgency, nocturia,
suprapubic pressure and pain.
1,
Although numerous theories regarding the
aetiology of IC have been proposed, the
pathogenesis remains unknown. Traumatic injury,
lymphatic obstruction and autoimmune disease are
among the suggested causes. Regardless of the
cause(s) of IC and other forms of non-infectious
cystitis, a number of reports suggest that the nervous
system is intimately involved in the development and
persistence of non-infectious cystitis. 5-7
Neurogenic inflammation affecting various organs,
including the skin, lungs, airways, gut, eye and
joints, has been reported in several species, including
humans.-1 A variety of stimuli, such as antigens,
heat, cold, bacterial or viral infection, and direct
stimulation of sensory nerves, can trigger the onset
of neurogenic inflammation.-1 Neuropeptides such
as substance P (SP), neurokinin A (NKA), calcitonin
gene-related peptide (CGRP) and vasoactive intesti-
nal peptide (VIP) are located in capsaicin sensitive
primary afferent nerves in the bladders of humans
and animals. 11,12 The release of SP, NKA and CGRP
has been correlated with smooth muscle contraction,
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vasodilatation, increased vascular permeability and
facilitated neurotransmitter release from intramural
nerves.1 SP, CGRP and VIP also mediate the sensory
function of capsaicin sensitive nervous control of the
micturition threshold and may facilitate spontaneous
bladder contraction. 14 Experimentally, antidromic
electrical stimulation of unmyelinated afferent nerve
fibres causes extravasation of Evans blue dye in the
urinary bladder of guinea-pigs. 15 Of the
neuropeptides present in the afferent sensory nerve
fibres, SP is thought to be the primary neurotrans-
matter responsible for initiation of neurogenic inflam-
mation, and CGRP is believed to play an important
role in facilitating and mediating the effects of SP. 16
Intravenous administration of SP also causes
extravasation of Evans blue dye and accumulation of
leukocytes in the bladder wall of experimental ani-
mals, and intravesical application of SP has a similar
effect.7.
8
Capsaicin, an extract of hot pepper, is a neurotoxin
for unmyelinated sensory nerve fibres which selec-
tively depletes SP and other neuropeptides from the
nerves at low doses and causes degeneration of
these nerves at high doses. Pretreatment of rats with
capsaicin significantly reduced the severity of xylene
induced cystitis, strongly suggesting the participation
of SP in the pathogenesis of this model of cystitis. 19
It has been reported that SP stimulates histamine
release from various tissues and isolated mast cells,
but this effect appears to be specific to the tissue
source of the mast cells and the species from which
these tissues and mast cells are obtained,a Prelimi-
nary studies in our laboratory have indicated that
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isolated guinea-pig bladder tissue releases histamine
in response to exposure to capsaicin or SP. We have
previously described the results of investigations
using a guinea-pig model for IC in which cystitis
develops in response to antigen sensitization and
challenge. 21,22 Antigen challenge of sensitized blad-
der tissue in this model causes release of histamine,
prostaglandins and leukotrienes, and this model of
cystitis was used to test the hypothesis that antigen
challenge of sensitized guinea-pig urinary bladder
tissue would stimulate SP release from sensory affer-
ent nerves and that exposure of guinea-pig bladder
tissue to inflammatory mediators would also stimu-
late release of SP from sensory afferent nerves, sug-
gesting a positive feedback mechanism for the ampli-
fication of cystitis.
Materials and Methods
Female, albino guinea-pigs (450-600 g) were used
in these experiments. Sensitized animals were ac-
tively sensitized to ovalbumin (OVA; chicken egg
albumin, ovalbumin grade V; Sigma Chemical Com-
pany, St Louis, MO) by administering three intraperi-
toneal injections ofOVA (10 mg/kg) at 48 h intervals.
Control animals received injections of the same vol-
ume of saline at the same time intervals. Twenty-one
days after the last injection, animals were sacrificed
for in vitro studies with sodium pentobarbital
(100 mg/kg, i.p.) or anaesthetized for in vivo studies
as described subsequently. For in vitro studies, uri-
nary bladders were removed and placed in physio-
logic salt solution (PSS) of the following composition
(mM): NaC1, 119; NaHiPO4, 1; KC1, 4.7; CaCl2, 2.5;
MgCl2, 0.5; NaHCO3, 25; and glucose, 11. The PSS
was maintained at 37C and aerated continuously
with a mixture of 95% O2 and 5% CO2 (pH 7.4).
Intravesical instillation of capsaicin, SP and OVA:
Guinea-pigs were anaesthetized with ketamine HC1
(40 mg/kg, i.p.) and xylazine (2.5 mg/kg, i.m.). A
polypropylene catheter with a closed end and side
openings (31/2 French Tom Cat Catheter, Sherwood
Medical, St Louis, MO) was introduced transureth-
rally into the bladder. The catheter was advanced
until the first drop of urine appeared. Urine was
drained from the bladder by applying light pressure
on the abdomen, and 3 ml of 0.9% saline, 3 l.tM
capsaicin, 100 btM SP, or OVA (1 btg/ml) was infused.
To ensure consistent contact of the bladder with
saline or the test substances, the animals received a
total of four instillations during a 2 h period. Some
guinea-pigs were sacrificed by pentobarbital over-
dose 30 min after the first instillation, and the remain-
der were sacrificed 2, 4, 8 and 20 h after the first
instillation. Bladders were removed and processed
for histology.
Tissues were fixed in neutral buffered formalin,
and 5m thick sections were stained with
haematoxylin and eosin or Giemsa. Stained tissue
sections were viewed and photographed using light
microscopy. Microscopic images were scanned
(CoolscanTM, Nikon Electronic Images, Melville, NY)
using Adobe Photoshop
TM 2.5.1 software (Adobe
Systems, Inc., Mountain View, CA) and printed with
a postscript imager (Lynotronic
TM Model 300,
Lynotype, Hell, Germany) at 2 540 dots per inch.
Measurement of plasma extravasation: Plasma
extravasation was quantified using a standard Evans
blue dye technique. 15 Briefly, Evans blue dye (Sigma
Chemical Company, St Louis, MO) was diluted in
0.9% saline (30 mg/ml), filtered with a 5.0 l.tm filter,
and injected (30 mg/kg) into a jugular vein 15 min
before intravesical instillation of saline, capsaicin, SP
or OVA. Guinea-pigs were sacrificed 4 or 18 to 20 h
after intravesical instillation of saline, capsaicin, SP or
OVA for determination of plasma extravasation. Im-
mediately prior to sacrifice, the thorax was opened,
and a blunt 13-gauge needle was passed into the
aorta via a left ventriculotomy. The right atrium was
incised to allow outflow of perfusate, and the animal
was perfused with 100ml of 0.9% saline at
100 mmHg pressure to remove intravascular dye. The
urinary bladder was removed, blotted three times on
filter paper and weighed. Tissues were incubated in
2 ml of 100% formamide (Sigma Chemical Company,
St Louis, MO) at 37C for 20 h to extract Evans blue
dye, and the dye concentration was determined
spectrophotometrically by light absorbance at
620nm. Tissue concentrations of dye were ex-
pressed as ng dye per mg of wet tissue weight.
Release of inflammatory mediatorsfrom bladder tis-
sue: Tissues were placed in individual test tubes
containing 2 ml of PSS (37 C) aerated with a mixture
of 95% O2 and 5% CO2. The PSS bathing the bladder
tissues in the test tubes was replaced with fresh
solution at 15 min intervals for 60 min. After 60 min,
tissues were incubated in fresh PSS for an additional
15 min, and this fluid was saved for subsequent
determination of spontaneous release of leuko-
trienes, prostaglandin D (POD2) or SP.
Leukotriene and PGD2 release from bladder tissue
incubated with SP was compared with release of
these compounds stimulated by sensitized tissues
exposed to OVA. Bladder tissue was incubated with
OVA (1 l.tg/ml) or SP (100 btM) for 30 min, and the
bath solution was collected for determination of
concentrations of PGD2 and leukotrienes.
To compare the capacity of various substances to
stimulate SP release from the bladder, other tissues
were challenged with capsaicin (3 btM), leukotriene
C (LTC4, 1001ttM), PGD (100btM), histamine
(100 l-tM), OVA (1 g/ml), or calcium ionophore
A23587 (100 btM) for 30 min, after which the bath
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solution was collected for subsequent determination
of SP release.
PGDe radioimmunoassay: PGD2 content was deter-
mined by radioimmunoassay as described previ-
ously. 23 This assay is sensitive to about 0.03 pmol/
0.1 ml.
vented by addition of a combination of peptidase
inhibitors, including captopril (5 x 10-6M), thiorphan
(1 10-6 M), and phosphoramidon (5 x 10.6 M).
SP was prepared in sodium metabisulphate (0.05%
in saline) containing these inhibitors. In experi-
ments investigating OVA-induced SP release, the PSS
used contained these compounds.
Leukotriene radioimmunoassay: The amount of
leukotriene released was measured by radioimmuno-
assay.
24 The limit of sensitivity of this assay is ap-
proximately 0.03 pmol as defined by that amount
required to inhibit [3H]-LTC binding by 10%. The
anti-peptidoleukotriene antibody is highly selective
with little affinity (cross-reactivity < 1%) for a variety
of heterologous eicosanoids. The antibody does not,
however, distinguish markedly between LTC4, LTD
and LTE4. Therefore, the results are presented as
leukotriene-like immunoreactivity (LLI).
Substance P radioimmunoassay: SP release was de-
termined by radioimmunoassay (RIA). Five l.tg of
synthetic [Tyr-O]-substance P was dissolved in 50 1
0.1 M phosphate buffer, pH 7.5. One mCi (5 t.tl) of
high specific activity 125I and 20 1 (20 t-tg) chlora-
mine-T was added, and the mixture was agitated for
45 s. The reaction was stopped by addition of 200 btl
saturated L-tyrosine. The labelled peptide was puri-
fied by gel filtration on a 0.9 30 cm column of G-
35 Sephadex (fine) eluted with 0.02 M phosphate
buffered saline, pH 7.5. [125I]-O-Tyr-SP was nearly
100% bindable with excess antibody. Standards (0 to
2 000 pg/ml) or sample (200 1) were added to 500 1
of anti-substance P (produced by G. P. Kozlowski;
1:8 000 initial dilution) in 0.1 M tris, pH 7.5 contain-
ing 0.5% normal rabbit serum. Tracer SP (100 1
containing 10000 cpm) was added to each tube and
mixed. Tubes containing only tracer, as well as non-
specific binding tubes containing PBS-NRS buffer
without antibody, were also prepared at this time.
Samples were mixed and incubated for 24 h at 4 %.
Bound tracer was precipitated by addition of 100 btl
of 1:4 sheep anti-rabbit IgG (produced in our labo-
ratory) and 1 000 btl of 3.3% polyethylene glycol in
PBS, and samples were centrifuged at 3000xg
for 20 min. The supernatant was discarded, and
bound radioactivity was counted in the pellet with a
gamma counter equipped with RIA data reduction
(Gammatrac Model 1290, Tm Analytic, Inc., Elk
Grove Village, IL). Characteristics of this assay in-
clude a minimum detectable dose less than 10 pg/
tube at ECs0, intra-assay variation less than 5%, and
inter-assay variation of approximately 8%. Cross-re-
activity studies (at EC50) showed 100% cross-reactivity
for SP, SP (4-11) and physalaemin, and less than
0.01% for metenkephalin and somatostatin. Cross-
reactivity of other peptides is being evaluated.
Substance P degradation in samples was pre-
Statistical analysis: Statistical analysis of the results
was performed with MinitabTM 8.0 (Minitab Inc.,
Rosemont, PA) software using analysis of variance
and Student’s t-test for paired or unpaired data. 25
The n values refer to one strip of tissue per ex-
perimental animal. All values were expressed as
mean + standard error of the mean (S.E.M.), and a
value of p < 0.05 was considered significant.
Results
Plasma extravasation: Intravesical instillation of sa-
line in control and sensitized animals, and OVA in
non-sensitized animals, failed to stimulate detectable
Evans blue dye extravasation. Four h after intra-
vesical instillation of capsaicin (3 M), SP (100 btM),
or OVA (1 btg/ml, in sensitized animals), Evans blue
dye extravasation had occurred (Fig. 1), and Evans
blue dye extravasation was not increased when
measured 18 to 20 h after intravesical instillation
of these compounds. In preliminary studies, extra-
vasation of Evans blue dye in response to 1 btg/ml
OVA (the concentration of OVA used consistently in
this model of cystitis21,22) instillation into sensitized
bladders was determined, and extravasation of Evans
blue dye in response to various concentrations of
intravesical capsaicin and SP was investigated. The
concentrations of capsaicin (3 btM) and SP (100 btM)
60
50
40
"
30
lO
FIG. 1. Evans blue dye extravasation in guinea-pig bladders 4 h after in vivo
intravesical infusion of ovalbumin (1 lg/ml, sensitized animals only), sub-
stance P (100 IM), or capsaicin (3 IM). Bladders in sensitized and naive
guinea-pigs infused with saline contained 2-5 lg Evans blue dye/g tissue
(n 12; data not shown). Asterisk indicates significant difference (p < 0.05)
between the effects of capsaicin (n= 10) and substance P (n= 8) or
ovalbumin (n=8). , ovalbumin, lg/ml; J, substance P, 1001M;
r-I, capsaicin, 3 M.
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FIG. 2. These photomicrographs illustrate the progression of histological changes in the bladder wall after intravesical instillation of capsaicin 3 #M, SP
100 #M or ovalbumin pg/ml (sensitized animals only). The progression of increasing severity of cellular infiltration was similar for these three groups, but
capsaicin-treated bladders exhibited significantly more haemorrhage. Examples of OVA-treated bladders from sensitized animals are shown, because the
changes are less obscured by haemorrhage. A, 30 min after challenge (approximately 200 x); B, 8 h (approximately 400 x); C, 12 h (approximately 600 x);
and D, 20 h after challenge (approximately 100 x). Arrows indicate urothelium (U) or blood vessels (BV).
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stimulating Evans blue extravasation in amounts
most closely approximating that in response to 1 lttg/
ml OVA were chosen for study to allow comparison
of the effects of these substances. Therefore, al-
though extravasation of Evans blue dye induced by
3M capsaicin was significantly higher than that
induced by 100 btM SP or 1 btg/ml OVA, this obser-
vation is a function of the relative concentrations of
capsaicin, SP and OVA chosen to be studied.
Leukocyte migration: Histological changes in the
bladder tissue after capsaicin or SP exposure (or
intravesical instillation of OVA in sensitized guinea-
pigs) appeared to follow a time course of increasing
severity between 30 min and 20 h post-exposure,
progressing from pronounced vasodilatation to
marginalization of granulocytes, followed by
diapdesis of leukocytes, initially restricted to the
perivascular area and subsequently spreading
through the submucosa and into the detrusor (Fig.
2). Eight hours after SP exposure, a profuse cellular
migration within the submucosa near the urothelium
was observed, and leukocytes were also present
between muscle bundles of the detrusor. Leukocytes
continued to migrate into these areas for the next
12 h, at which time the histological appearance of the
tissues stabilized.
Intravesical saline caused minimal histological
changes in the bladder wall (Fig. 3). However, sen-
sory nerve stimulation by intravesical instillation of
capsaicin induced intense vasodilatation, haemor-
rhage and leukocyte infiltration of the submucosa
and detrusor muscle. Granulocytes, most of which
were releasing their granules, were the predominant
leukocyte observed in the wall of the guinea-pig
bladder after capsaicin exposure, but lymphocytes
were also present. Similar effects were observed
after intravesical administration of substance P.
Intravesical instillation of OVA had no effect on the
histological appearance of the bladders of non-sen-
sitized animals and caused less haemorrhage than SP
or capsaicin exposure but a similar progression of
other histological changes when instilled into the
bladders of sensitized guinea-pigs.
Inflammatory mediator release: Substance P induced
PGD2 and LLI release from isolated sensitized and
control bladder tissue; OVA had no effect on unsen
sitized bladder tissue but stimulated PGD and LLI
release from sensitized bladder tissue (Fig. 4). Sub-
stance P stimulated release of relatively more
prostaglandins and less leukotrienes than OVA ex-
posure of sensitized bladder tissue. Increasing the
concentration of either SP (to 1 000 M) or OVA (to
100btg/ml), or increasing incubation time up to
90 min had no effect on PGD2 or LLI release (data
not shown).
Activation of sensory neurones by inflammatory
mediators: In vitro exposure of guinea-pig bladder
tissue to various mediators of inflammation, includ-
ing histamine, LTC and PGD2, stimulated SP release
(Fig. 5). In vitro exposure of bladder tissue from
sensitized guinea-pigs (but not from control animals)
to OVA also stimulated SP release. SP release in
response to these substances was compared with SP
release in response to activation of sensory nerves
with capsaicin and exposure of bladder tissue to a
non-physiological, non-immunological stimulus (cal-
cium ionophore). Calcium ionophore stimulated a
comparatively low amount of SP release at this con-
centration, while capsaicin stimulated significant SP
release, as expected.
Discussion
The results of these experiments clearly demon-
strate the effects of stimulation of sensory nerves on
inflammation of the guinea-pig urinary bladder. Al-
though the concentrations of SP evaluated in these
experiments exceed expected tissue concentrations,
the capacity of endogenous SP to produce similar
results is confirmed by the response of the bladder
to treatment with capsaicin. The concentrations of
capsaicin, SP and OVA used in these experiments
were selected to produce a similar degree of plasma
extravasation as measured by tissue concentrations
of Evans blue dye to allow direct comparison be-
tween the effects of these substances. The effects of
SP and capsaicin appear to be concentration depend-
ent, and lower concentrations used in preliminary
studies caused primarily mild interstitial oedema and
marginalization of leukocytes within the vasculature
despite marked vasodilatation.
Using this guinea-pig model of antigen induced
cystitis, the authors have previously described re-
lease of inflammatory mediators, including hista-
mine, PGD and leukotrienes, from the bladder sub-
sequent to antigen sensitization and challenge.
21,22
Other investigators have reported that antigen
sensitization results in alterations of micturition fre-
quency, voiding volume and cystometrographic data
in guinea-pigs, as well as increased uptake of
intravesical 14C-urea.26,27 The present experiments
demonstrate that OVA sensitization and subsequent
challenge of guinea-pig bladder causes release of SP,
and that SP is released from naive and sensitized
bladder tissue in response to histamine, PGD2, LTC4
and A-23587. These results indicate that SP is re-
leased in response to inflammatory mediators, and it
cannot be determined from these experiments
whether or not antigen sensitization and exposure
directly stimulates SP release.
In a cyclophosophamide induced cystitis model in
rats, Maggi et al. demonstrated that bladder
hyperreflexia was mediated through stimulation of
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FIG. 3. Representative photomicrographs of guinea-pig bladders 20 h after in vivo exposure to saline (., approximately 200 x); OVA (1, sensitized animals
only, g/ml, approximately 200 x); substance P ((3, 100 IM, approximately 400 x)" or capsaicin (13, 3 IM, approximately 200 x). Arrows indicate the
urothelium (U) or blood vessels (BV). Note marked vasodilatation induced by SP (C) and intense haemorrhage induced by capsaicin (13).
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FIG. 4. In vitro release of prostaglandin D (A) and leukotriene-like
immunoreactivity (B) by guinea-pig bladders incubated with substance P
(naive and sensitized animals) and ovalbumin (sensitized animals only).
Substance P stimulated release of significantly more PGD2, while
ovalbumin stimulated release of significantly more leukotriene..,
ovalbumin, lg/ml; I, substance P, 100 M.
unmyelinated afferent nerve fibres but that capsaicin
pretreatment actually increased plasma extravasation
as measured by Evans blue.’* Bilateral removal of the
pelvic ganglia almost eliminated plasma extrava-
sation within the bladder wall in response to
cyclophosphamide and suppressed enhancement of
plasma extravasation by capsaicin pretreatment. The
differences between this model and the present re-
suits may be explained in part by the authors’ obser-
vation that cyclophosphamide-induced cystitis is not
accompanied by a toxic effect on the afferent nerves
of the bladder but may be accompanied by stimula-
tion of the ganglia.
The calcium ionophore A-23587 is a non-immuno-
logic secretagogue for mast cell products. 29 Although
SP release in response to this compound was rela-
tively small at the concentration used, this finding
supports the capacity of mast cell degranulation to
stimulate SP release. Degranulating mast cells release
histamine, prostaglandins and leukotrienes, among
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FIG. 5. In vitro release of substance P in response to various stimuli. At the
concentrations of agonists used, capsaicin, histamine and PGD stimu-
lated release of comparable quantities of SP. Leukotriene C4, ovalbumin
(sensitized bladders only) and calcium ionophore A-23587 at the concen-
trations used stimulated release of smaller, but detectable, quantities of
SP. rll], A-23587, 100M; I1, LTC,, 1001M; ,, ovalbumin, lg/ml;
I, PGD, 100 IM; [], histamine, 100 IM; r-l, capsaicin, 3 M.
other inflammatory mediators. It is apparent that, at
least in the guinea-pig bladder, these compounds
stimulate release of SP, most likely from unmye-
linated afferent nerve fibres, which can then promote
and amplify inflammation. These effects may be
concentration dependent, and it is probable that SP
release could be altered by varying the concentration
of agonists used.
The capacity of SP to stimulate histamine release
from mast cells has been demonstrated repeatedly,
but sensitivity of mast cells to the effects of SP seems
to be specific to the species and tissue of origin of
the mast cells.2,23,3 In separate studies, we have
demonstrated SP-induced histamine release from
guinea-pig bladder, and confirmed release of PGD2
and leukotrienes from guinea-pig bladder in re-
sponse to SP (unpublished data). SP and SP ana-
logues have also been shown to stimulate release of
leukotrienes and thromboxane B from isolated,
perfused rat heart.3 Pretreatment of experimental
animals with capsaicin or antagonists for the primary
SP receptor (NK-1) prevents, or greatly reduces the
severity of, neurogenic inflammation, while inhibi-
tion of neutral endopeptidases which degrade
neuropeptides amplifies the effects of neurogenic
inflammation.1,1 Abelli et al. TM demonstrated that SP
administered intravenously to rats caused increased
post-capillary venular permeability within the urinary
bladder wall that was not exclusively NKl-receptor-
mediated. Yano et al. have suggested that SP-in-
duced increased vascular permeability and inflamma-
tory cell migration are mast cell-dependent phenom-
ena.32 While leukotrienes and other metabolites of
arachidonic acid released in response to SP may
come from a variety of sources, including mast cells,
vascular endothelium and smooth muscle, it appears
that mast cells are the sole source of histamine.,"
Neuropeptide-induced increased vascular permeabil-
ity clearly appears to be in part due to interaction of
SP with mast cells.
Mediators of Inflammation. Vol 3. 1994 195D. E. Bjorling, M. R. Saban and R. Saban
The role of mast cells in the pathogenesis of IC has
been the subject of considerable debate. IC is char-
acterized by chronic inflammation, and several re-
ports suggest a role for increased mast cell numbers
(and possibly activity) in the initiation and propaga-
tion of IC,33’34 although others question whether or
not mast cells are involved. 35 Participation of
neuropeptides in the pathogenesis of IC may not rely
solely on the presence and degranulation of mast
cells. SP and CGRP also have the capacity to modify
the function of other cells of the immune system. SP
acts as a chemoattractant and migratory stimulant for
monocytes and neutrophils, and SP receptors have
been identified on the surface of these cells. 36,7 SP
receptors have also been identified on the surface of
lymphocytes,8 and functional receptors for CGRP
have been characterized on lymphocytes and
macrophages in mice and rats.7,9,4 SP stimulates
lymphocyte proliferation, migration and im-
munoglobulin production.
7,8 CGRP stimulates
lymphocyte migration but may inhibit lymphocyte
proliferation.37,9 SP stimulates neutrophil antibody
dependent, cell mediated cytotoxicity and may facili-
tate neutrophil production of toxic oxygen species.
41
Several reports have described increased nerve
density in the bladder wall in the presence of IC,
including Hand in 1949 and more recent investiga-
tors.<7 Lasanen et a1.12 described a marked, extensive
depletion of VIP, neuropeptide Y, and SP-immuno-
reactive nerve fibres after distension of the rat blad-
der wall. This depletion of SP-containing sensory
nerves was reversible as early as 21 days later. A
decrease in active sensory nerves or decreased con-
centrations of neurotransmitters may contribute to
transient relief of pain provided IC patients by blad-
der distension. Increased SP activity was observed
during the recovery phase in previously distended rat
bladders; this may be related to neurogenic inflam-
mation and resumption of clinical symptoms. Intra-
vesical instillation of capsaicin in five patients with
hypersensitivity disorders of the lower urinary tract
provided temporary relief of symptoms in all pa-
tients, strongly suggesting participation of unmye-
linated afferent nerve fibres in sensation of pain in
the lower urinary tract.42 Systemic administration of
capsaicin to newborn rats decreased detrusor hyper-
reflexi and vascular permeability associated with
xylene-induced cystitis. 19 In humans, local applica-
tion of capsaicin has been shown to block the axon-
flare response and the flare response to intradermal
allergen and vasosactive inflammatory mediators.4
The results of the experiments described suggest
that bladder inflammation in the absence of infection
may at least in part be due to initiation of a cyclic
sequence of events which entails release of inflam-
matory mediators by a variety of stimuli which sub-
sequently themselves stimulate, directly or indirectly,
release of neuropeptides. Neuropeptides, particularly
SP, contribute to continued release of inflammatory
mediators, perpetuating and amplifying inflamma-
tion. Chronic bladder inflammation may thus be the
result of a variety of initiating factors. This also
suggests that, to be effective, therapeutic interven-
tions should be directed at more than one phase of
this cyclic process.
References
1. Hanno PM, Levin RM, Monson FC, et al. Diagnosis of interstitial cystitis. J Uro11990;
143: 278-281.
2. Kruger JM, Osborne CA, Goyal SM, et al. Clinical evaluation of cats with lower
urinary tract disease. JAm Vet Med Assoc 1991; 199: 211-216.
3. Holm-Bentzen M, Jacobsen F, Nerstrom B, et al. Painful bladder disease: clinical
and pathoanatomical differences in 115 patients. J Urol 1987; 138: 500-502.
4. Sant GR. Interstitial cystitis: pathophysiology, clinical evaluation, and treatment. In
Rous S, ed. Urology Annual, Norwalk, CT; Appleton & Lange, 1989; 171-196.
5. Hand JR. Interstitial cystitis: report of 223 (204 and 19 men). J Urol
1949; 61: 291-310.
6. Christmas TJ, Rode J, Chapple CR, Milroy EF, Turner-Warwick RT. Nerve fibre
proliferation in interstitial cystitis. Virchows Arch A Pathol Anat Histopathol 1990;
416: 447-451.
7. Lundeberg T, Liedberg H, Nordling L, Theodorsson E, Owzarski A, Ekman P.
Interstitial cystitis: correlation with fibres, mast cells and histamine. BrJ Urol
1993; "/1: 427-429.
8. Kowalski ML, Sliwinska-Kowalska M, Kaliner MA. Neurogenic inflammation,
cular permeability, and mast cells. II. Additional evidence indicating that mast cells
not involved in neurogenic inflammation. Jlmmunol 1990; 145: 1214-1221.
9. Sharkey KA. Substance P and calcitonin gene-related peptide (CGRP) in
gastrointestinal inflammation. Ann NYAcad Sci 1992; 664: 425-442.
10. Yonehara N, Imai Y, Shibutani T, Inoki R. Participation of substance P in inflam-
matory responses. Adv Exp Med Biol 1989; 24-/: 529-534.
11. Gu J, Blank MA, Huang WM, et al. Peptide-containing in human urinary
bladder. Urology 1984; 24: 353-357.
12. Lasanen LT, Tammela TL, Liesi P, Waris T, Polak JM. The effect of acute distension
vasoactive intestinal peptide (VIP), neuropeptide (NPY), and substance P (SP)
immunoreactive in the female rat urinary bladder. Urol Res 1992; 2{}:
259-263.
13. Maggi CA, Patacchini R, Sanicioli P, Giuliani S. Tachykinin antagonists and
capsaicin-induced contractions of the rat isolated urinary bladder: evidence for
tachykinin-mediated cotransmission. BrJ Pharmacol 1991; 1{}3:1535-1541.
14. Maggi CA. The dual function of capsaicin-sensitive sensory in the bladder
and urethra. Ciba Found Syrup 1990; 151: 77-90.
15. Lundberg JM, Brodin E, Hua X, Saria A. Vascular permeability changes and smooth
muscle contraction in relation to capsaicin-sensitive substance P afferents in the
guinea-pig. Acta Physiol Scand 1984; 12{}: 217-227.
16. Brokaw JJ, White GW. Calcitonin gene-related peptide potentiates substance P-
induced plasma extravasation in the rat trachea. Lung 1992; 1"/{}: 85-93.
17. Abelli L, Nappi F, Perretti F, Maggi CA, Manzini S, Giachetti A. Microvascular
leakage induced by substance P in the rat urinary bladder: involvement of cyclo-
oxygenase metabolites of arachidonic acid. JAuton Pharmaco11992; 12: 269-276.
18. Abelli L, Somma V, Maggi CA, et al. Effects of tachykinins and selective tachykinin
receptor antagonists vascular permeability in the rat lower urinary tract:
evidence for the involvement of NK-1 receptors. J Auton Pharmacol 1989; 9:
253-263.
19. Maggi CA, Abelli L, Giuliani S, et al. The contribution of sensory to xylene-
induced cystitis in rats. Neuroscience 1988; 26: 709-723.
20. Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC. Interaction of
neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 1989; 88:
70-78.
21. Christensen MM, Keith I, Rhodes PR, etal. A guinea pig model for study of bladder
contraction. J Uro11990; 144: 1293-1300.
22. Saban R, Christensen M, Keith I, et al. Experimental model for the study of bladder
mast cell degranulation and smooth muscle contraction. Sem Uro11991; 9: 88-101.
23. Undem BJ, Pickett WC, Lichtenstein LM, Adams GK III. The effect of indomethacin
immunologic release of histamine and sulfidopeptide leukotrienes from human
bronchus and lung parenchyma. Am Rev RespirDis 1987; 136: 1183-1187.
24. Aharony D, Dobson P, Berstein PR, Kusner EJ, Krell RD, Smith JB. Determination
of SRS-A release from guinea pig lungs by radioimmunoassay. Biochem Biophys
Res Comm 1983; 11"/: 574-579.
25. Bernard R, ed. Fundamentals of Biostatistics. Boston, MA: PWS Publishers, 1990;
442-450.
26. Kim YS, Longhurst PA, Wein AJ, Levin RM. Effects of sensitization female guinea
pig urinary bladder function: in vivo and in vitro studies. J Uro11991; 146: 454-457.
27. Kim YS, Levin RM, Wein AJ, Longhurst PA. Effects of sensitization the perme-
ability of the urothelium in the guinea pig urinary bladder. J Urol 1992; 14"/:
270-273.
28. Maggi CA, Lecci A, Santicioli P, Del Bianco E, Giuliani S. Cyclophosphamide cystitis
in rats: involvement of capsaicin-sensitive primary afferents. JAuton Nerv Syst 1992;
38: 201-208.
196 Mediators of Inflammation Vol 3 1994Neurogenic inflammation ofguinea-pig bladder
29. Vliagoftis H, Dimitriadou V, Boucher W, et al. Estradiol augments while tamoxifen
inhibits rat mast cell secretion. Int Arch Allergy Immunol 1992; 98: 398-409.
30. Assem ESK, Ghanem NS, Abdullah NA, Repke H, Foreman JC, Hayes NA. Substance
P and arg-pro-lys-pro-NH-C12-H25-induced mediator release from different mast cell
subtypes of rat and guinea-pig. Immunopharmacology 1989; 1"/: 119-128.
31. Nadel JA. Neurogenic inflammation in airways and its modulation by peptidases.
Ann NYAcad Sci 1992; 664: 408-414.
32. Yano H, Wershil BK, Arizono N, Galli SJ. Substance P-induced augmentation of
cutaneous vascular permeability and granulocyte infiltration in mice is mast cell
dependent. J Clin Invest 1989; 84: 1276-1286.
33. Nielsen KK, Kroman-Andersen B, Steven K, Hald T. Failure of combined
supratrigonal cystectomy and Mainz ileocecocystoplasty in intractible interstitial
cystitis: is histology and mast cell count reliable predictor for the outcome of
surgery? J Urol 1990; 144: 255-258.
34. Theoharides TC, Flarris N, Cronin CT, Ucci A, Meares E. Mast cell activation in
sterile bladder and prostate inflammation. IntArch AllergyApplImmunol 1990; 92:
281-286.
35. MacDermott JP, Charpied GL, Tesluk H, Stone AR. Can histological assessment
predict the outcome in interstitial cystitis? BrJ Urol 1991; {"/: 44-47.
36. Haines KA, Kolasinski SL, Cronstein BN, Reibman J, Gold LI, Weissmann G.
Chemoattraction of neutrophils by substance P and transforming growth factor-beta
is inadequately explained by current models of lipid remodeling. JImmuno11993;
151: 1491-1499.
37. McGillis JP, Mitsuhashi M, Payan DG. Immunomodulation by tachykinin
neuropeptides. Ann NYAcad Sci 1990; 594: 85-94.
38. Pascual DW, Bost KL, Xu-Amano J, Kiyono H, McGhee JR. The cytokine-like action
of substance P upon B cell differentiation. Reg Immunol 1992; 4: 100-104.
39. Umeda Y, Arisawa M. Characterization of the calcitonin gene-related peptide
receptor in T lymphocytes. Neuropeptides 1989; 14: 237-242.
40. Abello J, Kaiserlian D, Cuber JC, Revillard JP, Chayvialle JA. Characterization of
calcitonin gene-related peptide receptors and adenylate cyclase response in the
murine macrophage cell line P388 D1. Neuropeptides 1991; 19: 43-49.
41. Wozniak A, McLennan G, Betts WH, Murphy GA, Scicchitano R. Activation of
human neutrophils by substance P: effect FMLP-stimulated oxidative and
arachidonic acid metabolism and antibody-dependent cell-mediated
cytotoxicity. Immunology 1989; {8: 359-364.
42. Maggi CA, Barbanti G, Santicioli P, et al. Cystometric evidence that capsaicin-
sensitive modulate the afferent branch of micturition reflex in humans.
J Urol 1989; 142: 150-154.
43. Lundblad L, Lundberg L, Anggard A, Zetterstrom O. Capsaicin pretreatment inhibits
the flare component of the cutaneous allergic reaction in EurJ Pharmacol
1985; 113: 461-462.
ACKNOWLEDGEMENTS. This work supported by grant #1R01DK42897-CIA2 from
National Institutes of Health.
The authors acknowledge the contribution of Joel Armstrong from The Radio-
nuclide Laboratory, School of Veterinary Medicine, University of Wisconsin-
Madison for assistance in the substance P radioimmunoassays and Kermit Groothuis
for assistance with tissues processing for histology.
Received 17 January 1994;
accepted in revised form 15 February 1994
Mediators of Inflammation. Vol 3. 1994 197